Top 5 Takeaways Low severity and unusual pattern: The 2021–22 influenza season was characterized by low severity, with activity spanning from October 2021 through mid-June 2022, showcasing two distinct waves
Category: MMWR Booster
Top 5 Takeaways High Prevalence of Chronic Conditions: In 2019, 53.8% of young adults (18-34 years) had at least one chronic condition, and 22.3% had multiple conditions, highlighting a significant
Top 5 Takeaways Emergency Use Authorization Granted: The FDA issued an EUA for the Novavax COVID-19 vaccine on July 13, 2022, for primary immunization in adults aged ≥18 years. ACIP’s
Top 5 Takeaways Significant Global Progress: From 2016 to 2020, global coverage with the third dose of hepatitis B vaccine remained stable while coverage with the hepatitis B birth dose
Top 5 Takeaways Significant Increase in Unsupervised Melatonin Ingestions: Approximately 11,000 emergency department (ED) visits for unsupervised melatonin ingestion by infants and young children occurred during 2019–2022, making up about
Top 5 Takeaways High Effectiveness of Nirsevimab: Nirsevimab demonstrated a 90% effectiveness in preventing RSV-associated hospitalization among infants in their first RSV season. Median Time to Symptom Onset: The median
Top 5 Takeaways Significant Increase in Years of Potential Life Lost (YPLL): YPLL increased from 52,044 years during 2014–2015 to 88,788 years during 2020–2021, indicating a significant rise in premature
Top 5 Takeaways Stable Hypertension Prevalence: From 2017 to 2021, about one-third of U.S. adults reported having diagnosed hypertension, with no significant change in prevalence over the period. Increase in
Top 5 Takeaways Significant Increase in Intracranial Infections: During the first two years of the COVID-19 pandemic, an increase in pediatric intracranial infections was observed, with cases often diagnosed during
Top 5 Takeaways Higher Risk for Specific Conditions: Children and adolescents with previous COVID-19 showed higher rates of acute pulmonary embolism, myocarditis and cardiomyopathy, venous thromboembolic event, acute and unspecified